Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?

Klaus Bendtzen

    46 Citationer (Scopus)
    OriginalsprogEngelsk
    TidsskriftArthritis & Rheumatism
    Vol/bind63
    Udgave nummer4
    Sider (fra-til)867-70
    Antal sider4
    ISSN0004-3591
    DOI
    StatusUdgivet - 1 apr. 2011

    Citationsformater